Rasiele Biotech Private Limited
About Rasiele Biotech Private Limited
Data last updated:
Rasiele Biotech Private Limited was a private limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 20 January 2011.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2011PTC212907. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Pramod Kumar and Rekha Devi.
Its last annual general meeting (AGM) was held on 28 September 2017, and its latest financial statements are for the year ended 31 March 2017. The registered office was at 3073/77 F. Block – B Sant Nagar Burari, Delhi, India – 110084.
As per the financials filed for FY 2017, the company reported a revenue of ₹7.79 Lakh, a growth of 29% compared to the previous year. For the same year it recorded a net loss of ₹294 (net margin 0%) and EBITDA of ₹1,841 (EBITDA margin 0.2%).
Company details
Contact details
Rasiele Biotech Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address3073/77 F. Block – B Sant Nagar Burari, Delhi, India – 110084
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Rasiele Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rasiele Biotech is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Rasiele Biotech Private Limited, buy the company report.
Financials of Rasiele Biotech Private Limited
FY 2017 filings availableRasiele Biotech Private Limited reported revenue of ₹7.79 Lakh (up 29% YoY) for FY 2017.
Compounded Annual Growth Rate (CAGR)
Revenue rose 29% in the latest year. EBITDA fell 96% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹7.79 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1,841 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹294 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 0.2% | ||
| Net Profit Margin | 0% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Rasiele Biotech Private Limited, buy the company report.
Board of directors of Rasiele Biotech Private Limited
Rasiele Biotech has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pramod Kumar | Director | 24 Jan 2012 | 14 Years 9 Months | As last reported |
| Rekha Devi | Additional Director | 12 May 2017 | 9 Years 5 Months | As last reported |
Peer comparison
Rasiele Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Meerutzone Neurosurgical Private Limited | ₹7.82 Lakh (FY 2024) | -55.0% | Meerut, Uttar Pradesh, India | |||
| Medswiss Hospicare & Research Institute Private Limited | ₹7.82 Lakh (FY 2025) | 263.0% | Kanpur, Uttar Pradesh, India | |||
| Rigid Health Care Private Limited | ₹7.8 Lakh (FY 2025) | 713.0% | Chennai, Tamil Nadu, India | |||
| Drongo Healthcare Private Limited | ₹7.8 Lakh (FY 2024) | -8.0% | Ghaziabad, Uttar Pradesh, India | |||
| Nutri Physician Private Limited | ₹7.8 Lakh (FY 2024) | 51.0% | Bangalore, Karnataka, India | |||
| Rasiele Biotech Private Limitedthis company | ₹7.79 Lakh (FY 2017) | -₹294 | 0% | 29.0% | Delhi, India | |
| Suchetana Lifenhancement Private Limited | ₹7.78 Lakh (FY 2020) | 132162.0% | Mysore, Karnataka, India | |||
| Rogahara Medicare Private Limited | ₹7.77 Lakh (FY 2022) | 28.0% | Palakkad, Kerala, India | |||
| Helik Healthcare Private Limited | ₹7.77 Lakh (FY 2024) | Varanasi, Uttar Pradesh, India | ||||
| Jaipur Health Club Private Limited | ₹7.76 Lakh (FY 2022) | -36.0% | Jaipur, Rajasthan, India | |||
| Stembionics Private Limited | ₹7.75 Lakh (FY 2019) | 2.0% | Howrah, West Bengal, India |
To see the full peer comparison of Rasiele Biotech Private Limited, buy the company report.
Auditor
Rasiele Biotech Private Limited is audited by JSG & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| JSG & Associates | FY 2017 | 025358N |
Shareholding
The shareholding of Rasiele Biotech Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Rasiele Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rasiele Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rasiele Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Rasiele Biotech has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Rasiele Biotech Private Limited, buy the company report.
Recent activity
Rasiele Biotech Private Limited has 5 board changes on record since 2012: 2 appointments and 3 cessations. The latest: Rekha Devi was appointed as Additional Director on 12 May 2017.
Frequently asked questions
Rasiele Biotech has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Rasiele Biotech was a private limited company based in Delhi, India. The company worked in other hospital and medical care activities, within the healthcare industry. It was incorporated on 20 January 2011 and is registered under CIN U24232DL2011PTC212907. The company has been struck off by the Registrar of Companies and is no longer operational.
Rasiele Biotech had 2 directors:
- Pramod Kumar - Director
- Rekha Devi - Additional Director
The CIN (Corporate Identification Number) of Rasiele Biotech is U24232DL2011PTC212907. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Rasiele Biotech is at 307377 F. Block – B Sant Nagar Burari, Delhi, India – 110084.
Rasiele Biotech was incorporated on 20 January 2011. It is registered with the Registrar of Companies, Delhi.
The latest financial statements of Rasiele Biotech on record with the MCA are for the year ended 31 March 2017. Its last annual general meeting was held on 28 September 2017. Year-wise statements from 2015 are in the company report.
No. Rasiele Biotech has 1 GST registration on record and it is cancelled or inactive.
Rasiele Biotech operated in the healthcare industry, in the other hospital and medical care activities segment. It worked in this industry before it was struck off.
The peers of Rasiele Biotech by revenue are Meerutzone Neurosurgical Private Limited, Medswiss Hospicare & Research Institute Private Limited, Rigid Health Care Private Limited, Drongo Healthcare Private Limited, Nutri Physician Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Rekha Devi was appointed as Additional Director on 12 May 2017. Som Dutt ceased to be Director on 12 May 2017. Pramod Kumar ceased to be Additional Director on 29 Sep 2012. Rasiele Biotech has 5 board changes on record in total.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
